Participant flashtalks
Each participant introduced themselves and their work — scientists, entrepreneurs and activists explaining what brought them to OSP3 and the projects they are building to achieve affordable medicine for all.
OSP3 · 2019
Science, License, Community
A singular gathering of researchers, entrepreneurs, industry professionals, funders and NGOs working toward affordable medicine for all.
Affordable medicine is a grand challenge of our time. Open source brings the promise of efficient, robust and inclusive routes to discovery. While great progress has been made in opening up the discovery and development of new medicines, major barriers remain to open source medicines reaching patients.
The task in Paris was to learn about and spark new initiatives, to understand the main challenges together, and to propose new, realistic solutions for implementation.
OSP3 followed the first conference at the Bellagio Center in 2014 and the second at Castle Rauischholzhausen in 2015. Partners and sponsors have included The Rockefeller Foundation, Open Society Foundations and Tata Trusts. OSP3 was sponsored by CRI Research, with support from DRUID – Giessen University.
What the OSP3 programme set out to do.
Each participant introduced themselves and their work — scientists, entrepreneurs and activists explaining what brought them to OSP3 and the projects they are building to achieve affordable medicine for all.
Jaykumar Menon on why we need an alternative pharmaceutical system, and Dr. UC Jaleel on the open lab in India working with students to discover new molecules.
A video put together at the conference to mark World TB Day on March 24, 2019, as the movement reaffirmed its commitment to ending tuberculosis.
48 people took part in OSP3.
Help advance open science through AI, global collaboration, and accessible healthcare. Volunteer or donate to make a lasting impact.
